-

Shareholder Alert: Robbins LLP Reminds Investors Colony Capital, Inc. (CLNY) Sued for Misleading Shareholders

SAN DIEGO & LOS ANGELES--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Colony Capital, Inc. (NYSE: CLNY) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 9, 2019 and May 7, 2020. Colony is a leading global investment firm with assets under management of $55 billion.

If you suffered a loss as a result of Colony's misconduct, click here.

Colony Capital, Inc. (CLNY) Accused of Misleading Shareholders

According to the complaint, on September 30, 2019, Colony announced that Blackstone (NYSE: BX) would acquire Colony Industrial, the industrial real estate assets and affiliated operating platform for $5.9 billion. Colony claimed the sale would "achieve compelling returns for [its] investors and generate significant liquidity." Then, on November 7, 2019, Colony Credit Real Estate (NYSE: CLNC) announced that after an expert valuation, it would begin reporting operations of its Core portfolio and Legacy, Non-Strategic portfolio separately. Unbeknownst to shareholders, Colony's sale of its industrial real estate portfolio and the bifurcation of its real estate portfolio were likely to negatively impact Colony's financial and operating results. On November 8, 2019, Colony revealed a GAAP net loss that "included reductions of goodwill, real estate and provision for loan losses totaling $540.3 million." Colony noted that $387 million of that loss was due to the pending sale of the Company's industrial investment management business as well as the decrease in management fees from Colony Real Estate, Inc. related to impairments due to its portfolio bifurcation. Colony's stock price fell almost 9% to close at $5.00 per share. Finally, on May 8, 2020, Colony disclosed that its portfolio companies had defaulted on $3.2 billion of debt and that Colony had received notice of acceleration covering $780 million of the defaulted debt. On this news, Colony's stock price fell almost 4% to close at $2.02 per share.

Colony Capital, Inc. (CLNY) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against Colony settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:CLNY

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Reminds Primo Brands Corporation Stockholders on the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the PRMB class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada. Who is part of the class? The case purportedly represents stockholders who purchased or otherwise acquired (i) the co...

Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri...

Robbins LLP Reminds Freeport-McMoran Inc. Stockholders of the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the FCX class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Freeport-McMoran Inc. (NYSE: FCX) is a mining company. What is the class period? February 15, 2022 - September 24, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport during the class period because the Company allegedly misled investors regarding safety at its mines. For more information, submit a form, email attorney Aaron Dumas, Jr....
Back to Newsroom